These are a selection of the most recent publications our team has published.
Ramos KJ, Kapnadak SG, Bradford MC, Somayaji R, Morrell ED, Pilewski JM, Lease ED, Mulligan MS, Aitken ML, Gries CJ, Goss CH. Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study. Chest. 2020 Apr; 57(4):898-906.
Verdial FC, Madtes DK, Hwang B, Mulligan MS, Odem-Davis K, Waworuntu R, Wood DE, Farjah F. Prediction Model for Nodal Disease Among Patients With Non-Small Cell Lung Cancer. Ann Thorac Surg. 2019 Jun;107(6):1600-1606.
Ramos KJ, Harhay MO, Mulligan MS. Which Shall I Choose? Lung Transplantation Listing Preference for Individuals with Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2019 Feb;16(2):193-195.
Berfield KS, Farjah F, Mulligan MS. Video-Assisted Thoracoscopic Lobectomy for Lung Cancer. Ann Thorac Surg. 2019 Feb;107(2):603-609.
Verdial FC, Madtes DK, Hwang B, Mulligan MS, Odem-Davis K, Waworuntu R, Wood DE, Farjah F. Prediction Model for Nodal Disease Among Patients With Non-Small Cell Lung Cancer. Ann Thorac Surg. 2019 Jun;107(6):1600-1606.
Thornblade LW, Mulligan MS, Odem-Davis K, Hwang B, Waworuntu RL, Wolff EM, Kessler L, Wood DE, Farjah F. Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018 Nov;106(5):1460-1467.
Hwang B, Liles WC, Waworuntu R, Mulligan MS. Pretreatment with bone marrow-derived mesenchymal stromal cell-conditioned media confers pulmonary ischemic tolerance. J Thorac Cardiovasc Surg. 2016 Mar; 151(3):841-6.
Merry HE, Phelan P, Hwang B, Mulligan MS. Validating the use of short interfering RNA as a novel technique for cell-specific target gene knockdown in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2016 Feb; 151(2):499-506.